Wednesday 11 June 2014

Expression Proteomics Market - Global Industry Analysis,Trends And Forecast, 2013 - 2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Expression Proteomics Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Expression proteomics includes the study of the dysregulated proteins as a function of stimulation or patient condition. The patient condition depends on the disease or specific drugs related to any disease. The market for expression proteomics is segmented into four major categories, on the basis of applications, by expression system, by products and by the End users. 


By expression system, market of expression proteomics consists of four segments including:
  • Mammalian
  • Prokaryotes
  • Baculovirus
  • Yeast
Among the expression system segments, the major market share is commanded by prokaryotic segment. The use of Escherichia Coli (E.Coli) is mostly preferred as a host cell due to its easy availability and cheap protein expression and production. Mammalian segment is also showing increased growth as demand for therapeutic proteins has increased leading to need for proteins with post-translational modification and increasing use of mammalian expression systems. 

The market for expression proteomics on the basis of the product is differentiated into four major segments which include:

  • Competent Cells 
  • Expression vectors
  • Instruments
  • Reagents
In the product segment for expression proteomics market, reagents is the major revenue generating product driven by the demand of immunoassays, microarray reagents and spectroscopy reagents. These reagents are easy to use and are less expensive comparatively and therefore, used in large number for transfection and maintenance of cell lines. Instruments are further divided into six major categories according to the techniques involved in expression proteomics namely microarrays, mass spectrometers, NMR spectrometers, chromatography, electrophoresis, surface plasmon resonance and X-ray crystallography. Among these protein microarrays are dominating the market followed by spectroscopy technique. 

On the basis of application of expression proteomics, the market is divided into three segments including:
  • Industrial proteins
  • Research applications
  • Therapeutic proteins
Among these segments, therapeutic proteins are dominating the market for expression proteomics due to its versatile advantage over other small molecule drugs to alleviate diseases. On the basis of end users, the market is majorly classified into three parts namely pharmaceutical, biotechnology and research organizations. 

The market for expression proteomics is growing at faster pace majorly driven by the globally increasing intensity in research in the pharmaceutical and biological sector. Additionally, the factors such as increased demand for personalized medicine, technological advancement and increasing use of proteomic outcomes in diagnosis and drug discovery also propels the market growth. However, reduction in funding towards sequestration cuts in U.S., high cost of expression proteomics tools, difficulty in gaining regulatory approvals and dearth of qualified researchers are some of the factors which are restraining the growth of this market to some extent. 

North America currently leads the global market for expression proteomics followed by Europe. The major factors driving the expression proteomics market in these regions are the technological advancements and rising demand for the expression proteomics in personalized medicines. The expression proteomics market in Asia-Pacific is also showing rapid growth due to increasing government and private funding towards research and development in countries such as Japan, India, Australia and China. The major key players in the expression proteomics market include ActivX Biosciences, Inc, Agilent Technologies, Inc., Life Technologies Corporation, New England Biolabs, Inc., QIAGEN, Takara Bio, Inc., Bio-Rad Laboratories, Merck Millipore, Hybrigenics SA , Tyrian Diagnostics, Ltd, Luminex Corporation, Promega Corporation, Danaher Corporation , Caprion Proteomics, Inc Sigma-Aldrich Corporation and Thermo Fischer Scientific, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Research Report:-

Tuesday 3 June 2014

Circadian Rhythm Sleep Disorders Market  - Global Industry Strategic Report, 2013 — 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.Sleep disorder is a deviation in the normal sleeping pattern. It can also be defined as difficulty related to sleeping that includes falling asleep at inappropriate time, excessive sleep and abnormal behavior associated with the sleep. Sleep disorders are classified into four categories namely, dyssomnias, parasomnias, proposed sleep disorder and medical disorder.

Browse Full Report with TOC:

Dyssomnia is the disturbance in quality, time and amount of sleep. It is further classified as intrinsic sleep disorder, circadian rhythm sleep disorder and extrinsic sleep disorder. Circadian Rhythm Sleep Disorders (CRSD) are a family of disorders that affects the sleep of an individual.
The various types of CRSD are as follows:
  • Delayed Sleep Phase Disorder (DSP)
  • Jet Lag Disorder
  • Irregular Sleep-Wake Rhythm
  • Free-Running (nonentrained) type
  • Shift Work Disorder
  • Advanced Sleep Phase Disorder (ASP)
Increasing geriatric population coupled with rising prevalence of chronic disorders are some of the major factors driving the growth of CRSD market globally. The global population is aging, especially in developed countries that includes the U.S., Europe and Japan. It has been estimated that the global geriatric population would rise from 760 million (11%) in 2011 to 2 billion (2050). Thus, increasing geriatric population accentuates the growth of this market. However, lack of awareness among the patient population is one of the restraining factors for this market.

Geographically, North America and Europe accounted for the largest share of the global CRSD market owing to increasing geriatric population and rising prevalence of chronic diseases. According to Eurostat (European Commission) report in 2013, around 17.8% of the European population was above the age of 65 years. Thus, this increase in geriatric population propels the growth of CRSD in European region.

Vanda Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, VU University Medical Center, U.S. Centers of Disease Control and Prevention are some of the manufacturers and research organizations engaged in developing therapeutics for the development of CRSD market.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

More Reports on Pharmaceutical Market: 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY — 12207
United States
Tel: +1-518-618-1030

Browse Market Research Report:-